Intravenous immunoglobulin in clinical practice

Ewa Bernatowska; Janina Jastrzębska-Piotrowska; John Hooper

eISSN: 1644-4124
ISSN: 1426-3912

Central European Journal of Immunology

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

4/2002
vol. 27

Send email

Copy url:

abstract:

Intravenous immunoglobulin in clinical practice

Ewa Bernatowska

,

Janina Jastrzębska-Piotrowska

,

John Hooper

(Centr Eur J Immunol 2002; 27 (4): 169–175)

Online publish date: 2003/12/19

Abstract

Although initially used for immunodeficiency disorders, intravenous immunoglobulin (IVIG) has been utilized as a prophylactic and therapeutic agent in a variety of other clinical conditions. The rapid growth in IVIG use is the result of improvements in IVIG preparations and reports of benefits in a number of unexpected clinical applications. IVIG has been used in such diverse diseases as primary immunodeficiencies, pediatric AIDS, low birth weight infants, bone marrow transplantation, chronic lymphocytic leukemia, idiopathic thrombocytopenic purpura, Kawasaki syndrome and demylinating polyneuropathies. However, important questions about doses and mechanisms still remain. This review describes clinical applications of IVIG that are clearly indicated and approved by national regulatory agencies. Other clinical applications supported by convincing clinical trials are also described.

keywords:

Intravenous immunoglobulin in clinical practice

Ewa Bernatowska , Janina Jastrzębska-Piotrowska , John Hooper

intravenous immunoglobulin, immunoglobulin therapy

Ewa Bernatowska

,

Janina Jastrzębska-Piotrowska

,

John Hooper